SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection
Western Health and Social Care TrustcontractFind a Tender ↗Ref ocds-h6vhtk-05ddfeProcurement Act 2023pending
Estimated value
—
Awarded value
£4.6m
Awarded 10 Nov 2025
Suppliers
1
Lots
1
1 awarded
Published
10 Nov 2025
Description
Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 30/11/2028.
Scope
- Reference
- WT2025-07
- Commercial tool
- Standalone contract
Submission & procedure
- Procedure
- Direct award
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£4.6m
Award date
10 Nov 2025
Contract start
01 Dec 2025
Contract end
30 Nov 2028
Awarded to
NP
CH 00119006
Awarded suppliers· 1 supplier
Awarded 10 Nov 2025 · Contract period 01 Dec 2025 — 30 Nov 2028
Award value
£4.6m
Other contracts from Western Health and Social Care Trust
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to NOVARTIS PHARMACEUTICALS UK LIMITED· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| REVOLADE (ELTROMBOPAG) TABLETS, 28 tablet | contract | — | 07 Jul 2026 |
| Utathera 7400MBq/20.5-25ml solution | contract | — | 30 Jun 2026 |
| REVOLADE (ELTROMBOPAG) TABLETS, 28 tablet | contract | — | 17 Jun 2026 |
| Transitional Drugs 7 | contract | — | 05 Jun 2026 |
| TRAMETINIB 2MG TABLETS, 30 tablet, pack, PACK OF 1 | contract | — | 05 May 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 16 Apr 2026 |
| Generic, Branded Generic & Proprietary Medicinal Products - Group 17 | contract | — | 12 Jan 2026 |
| NHS National Framework Agreement for Omalizumab | contract | — | 30 Dec 2025 |
| NHS National Framework for Generics Housekeeping | contract | — | 22 Dec 2025 |
| Contract for Netspot (Gallium Ga 68 Dotatate) | contract | — | 08 Dec 2025 |